Literature DB >> 16574533

Predictive factors of a fulminant course in acute myocarditis.

Cheng-Han Lee, Wei-Chuan Tsai, Chih-Hsin Hsu, Ping-Yen Liu, Li-Jen Lin, Jyh-Hong Chen.   

Abstract

BACKGROUND: Patients who develop fulminant myocarditis often die of sudden cardiac arrest, arrhythmia, or severe heart failure soon after onset if they do not receive percutaneous cardiopulmonary support in time. The purpose of this study was to identify the risk factors of clinical symptoms/signs or laboratory findings that could predict the fulminant course of acute myocarditis. METHODS AND
RESULTS: Thirty-five patients (mean age 28 +/- 8 years, 17 males) who had been admitted to intensive care unit with the diagnosis of acute myocarditis by clinical presentations were retrospectively recruited. They were divided into the fulminant group (n = 11) and the non-fulminant group (n = 24). Clinical features, laboratory data, and images on admission were analyzed. Overall in-hospital mortality was 17% (6/35). Mortality was higher in the fulminant group (45% vs. 4%, p = 0.027). Multivariate analysis revealed that prolongations of the QRS complex (118 +/- 27 vs. 88 +/- 10 ms, p = 0.048) and depressed left ventricular ejection fraction (41 +/- 7% vs. 57 +/- 7%, p = 0.027) were the only independent factors significantly associated with the fulminant course of acute myocarditis.
CONCLUSION: The in-hospital mortality of acute fulminant myocarditis was high. Prolongations of the QRS complex and depressed left ventricular ejection fraction on admission were independent positive predictors for the development of acute fulminant myocarditis.

Entities:  

Mesh:

Year:  2006        PMID: 16574533     DOI: 10.1016/j.ijcard.2005.04.014

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  14 in total

1.  Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support.

Authors:  Kohki Ishida; Hiroshi Wada; Kenichi Sakakura; Norifumi Kubo; Nahoko Ikeda; Yoshitaka Sugawara; Junya Ako; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2011-12-28       Impact factor: 2.037

2.  Factors and values at admission that predict a fulminant course of acute myocarditis: data from Tokyo CCU network database.

Authors:  Osamu Inaba; Yasuhiro Satoh; Mitsuaki Isobe; Takeshi Yamamoto; Ken Nagao; Morimasa Takayama
Journal:  Heart Vessels       Date:  2017-03-03       Impact factor: 2.037

Review 3.  Diagnosis and treatment of viral myocarditis.

Authors:  Jason C Schultz; Anthony A Hilliard; Leslie T Cooper; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

4.  The role of extracorporeal life support in acute myocarditis: a bridge to recovery?

Authors:  D Bradford Sanders; Steven R Sowell; Brigham Willis; John Lane; Christopher Pierce; Stephen Pophal; Francisco A Arabia; John J Nigro
Journal:  J Extra Corpor Technol       Date:  2012-12

5.  The Prognostic Role of QTc Interval in Acute Myocarditis.

Authors:  Yuan Hung; Wei-Hsiang Lin; Chin-Sheng Lin; Shu-Meng Cheng; Tsung-Neng Tsai; Shih-Ping Yang; Wen-Yu Lin
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

6.  Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature.

Authors:  Sorel Goland; Lawrence S C Czer; Robert J Siegel; Steven Tabak; Stanley Jordan; Daniel Luthringer; James Mirocha; Bernice Coleman; Robert M Kass; Alfredo Trento
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

Review 7.  Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.

Authors:  Bernhard Maisch; Volker Ruppert; Sabine Pankuweit
Journal:  Curr Heart Fail Rep       Date:  2014-06

8.  Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis.

Authors:  Yi-Jung Chang; Hsiang-Ju Hsiao; Shao-Hsuan Hsia; Jainn-Jim Lin; Mao-Sheng Hwang; Hung-Tao Chung; Chyi-Liang Chen; Yhu-Chering Huang; Ming-Han Tsai
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

9.  Clinical characteristics and treatment effects of astragalus injection in non-pediatric patients with acute fulminant myocarditis.

Authors:  Hongmin Yang; Yang Lu; Han Yang; Jing Yuan
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

10.  Influence of echocardiographic measurements and renal impairments on the prognosis of fulminant myocarditis.

Authors:  Mingzhu Xu; Tingbo Jiang; Yafeng Zhou; Xiangjun Yang
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.